nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—P2RY12—abdominal aortic aneurysm	0.918	1	CbGaD
Epoprostenol—PTGIS—artery—abdominal aortic aneurysm	0.00902	0.199	CbGeAlD
Epoprostenol—P2RY12—artery—abdominal aortic aneurysm	0.00812	0.179	CbGeAlD
Epoprostenol—Treprostinil—P2RY12—abdominal aortic aneurysm	0.00623	1	CrCbGaD
Epoprostenol—P2RY12—blood plasma—abdominal aortic aneurysm	0.00609	0.134	CbGeAlD
Epoprostenol—PTGIR—artery—abdominal aortic aneurysm	0.00518	0.114	CbGeAlD
Epoprostenol—PTGIS—Nicotinamide salvaging—PTGS2—abdominal aortic aneurysm	0.00434	0.142	CbGpPWpGaD
Epoprostenol—PTGIR—blood plasma—abdominal aortic aneurysm	0.00389	0.0857	CbGeAlD
Epoprostenol—PTGIS—connective tissue—abdominal aortic aneurysm	0.0036	0.0794	CbGeAlD
Epoprostenol—PTGER1—kidney—abdominal aortic aneurysm	0.00285	0.0629	CbGeAlD
Epoprostenol—PTGIS—Nicotinate metabolism—PTGS2—abdominal aortic aneurysm	0.00231	0.0753	CbGpPWpGaD
Epoprostenol—PTGIR—connective tissue—abdominal aortic aneurysm	0.00207	0.0456	CbGeAlD
Epoprostenol—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—abdominal aortic aneurysm	0.0019	0.0621	CbGpPWpGaD
Epoprostenol—PTGIR—kidney—abdominal aortic aneurysm	0.00176	0.0388	CbGeAlD
Epoprostenol—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00139	0.0306	CbGeAlD
Epoprostenol—PTGIR—spinal cord—abdominal aortic aneurysm	0.00137	0.0302	CbGeAlD
Epoprostenol—PTGIS—Eicosanoid Synthesis—PTGS2—abdominal aortic aneurysm	0.00124	0.0404	CbGpPWpGaD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.00103	0.0338	CbGpPWpGaD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.000757	0.0247	CbGpPWpGaD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.000757	0.0247	CbGpPWpGaD
Epoprostenol—PTGIS—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000687	0.0224	CbGpPWpGaD
Epoprostenol—PTGIR—Platelet homeostasis—NOS2—abdominal aortic aneurysm	0.000479	0.0156	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—AGT—abdominal aortic aneurysm	0.000477	0.0156	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.000471	0.0154	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.000471	0.0154	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.000441	0.0144	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000403	0.0132	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000403	0.0132	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.000371	0.0121	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—SERPINE1—abdominal aortic aneurysm	0.000367	0.012	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000332	0.0108	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SELL—abdominal aortic aneurysm	0.000332	0.0108	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.000311	0.0102	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000307	0.01	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000307	0.01	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SELL—abdominal aortic aneurysm	0.000305	0.00996	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000296	0.00965	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.000287	0.00935	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.000287	0.00935	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000277	0.00904	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000275	0.00897	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000267	0.00871	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000261	0.00851	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000246	0.00801	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000246	0.00801	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.000236	0.00771	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000233	0.00762	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000203	0.00663	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—LRP1—abdominal aortic aneurysm	0.000194	0.00634	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000191	0.00622	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000188	0.00613	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000187	0.0061	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000187	0.0061	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000174	0.00567	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000174	0.00567	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000173	0.00564	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000173	0.00564	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AAAS—abdominal aortic aneurysm	0.000169	0.0055	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000158	0.00515	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000158	0.00515	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000155	0.00505	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—LDLR—abdominal aortic aneurysm	0.000147	0.00481	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000146	0.00478	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000143	0.00468	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000143	0.00467	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000142	0.00464	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000142	0.00464	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AAAS—abdominal aortic aneurysm	0.000141	0.00461	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NCF1—abdominal aortic aneurysm	0.000138	0.00449	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000132	0.00429	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000132	0.00429	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—LDLR—abdominal aortic aneurysm	0.000123	0.00402	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000118	0.00384	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—NOS2—abdominal aortic aneurysm	0.000117	0.00381	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000115	0.00375	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000111	0.00363	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000108	0.00354	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000108	0.00354	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000108	0.00353	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—NOS2—abdominal aortic aneurysm	0.000107	0.00351	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000106	0.00345	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000106	0.00345	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000104	0.0034	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LRP1—abdominal aortic aneurysm	9.96e-05	0.00325	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LRP1—abdominal aortic aneurysm	9.96e-05	0.00325	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SERPINE1—abdominal aortic aneurysm	9.83e-05	0.00321	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	9.83e-05	0.00321	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	9.6e-05	0.00313	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	9.6e-05	0.00313	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	9.31e-05	0.00304	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	9.31e-05	0.00304	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—MMP3—abdominal aortic aneurysm	9.29e-05	0.00303	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SERPINE1—abdominal aortic aneurysm	9.05e-05	0.00295	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—MMP3—abdominal aortic aneurysm	8.55e-05	0.00279	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	8.55e-05	0.00279	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LDLR—abdominal aortic aneurysm	8.2e-05	0.00268	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AGT—abdominal aortic aneurysm	8.08e-05	0.00264	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCF1—abdominal aortic aneurysm	7.67e-05	0.0025	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—APOE—abdominal aortic aneurysm	7.63e-05	0.00249	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LDLR—abdominal aortic aneurysm	7.55e-05	0.00246	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LDLR—abdominal aortic aneurysm	7.55e-05	0.00246	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AGT—abdominal aortic aneurysm	7.44e-05	0.00243	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	7.44e-05	0.00243	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AGT—abdominal aortic aneurysm	7.34e-05	0.00239	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—abdominal aortic aneurysm	7.11e-05	0.00232	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCF1—abdominal aortic aneurysm	7.06e-05	0.0023	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCF1—abdominal aortic aneurysm	7.06e-05	0.0023	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AGT—abdominal aortic aneurysm	6.75e-05	0.0022	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AGT—abdominal aortic aneurysm	6.75e-05	0.0022	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AGT—abdominal aortic aneurysm	6.52e-05	0.00213	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—APOE—abdominal aortic aneurysm	6.39e-05	0.00208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.16e-05	0.00201	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—abdominal aortic aneurysm	6.04e-05	0.00197	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SERPINE1—abdominal aortic aneurysm	5.98e-05	0.00195	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	5.67e-05	0.00185	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	5.67e-05	0.00185	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—abdominal aortic aneurysm	5.56e-05	0.00181	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	5.56e-05	0.00181	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.49e-05	0.00179	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—abdominal aortic aneurysm	5.22e-05	0.00171	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.05e-05	0.00165	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.05e-05	0.00165	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	4.47e-05	0.00146	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—abdominal aortic aneurysm	4.38e-05	0.00143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AGT—abdominal aortic aneurysm	4.33e-05	0.00141	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APOE—abdominal aortic aneurysm	4.25e-05	0.00139	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGT—abdominal aortic aneurysm	3.99e-05	0.0013	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGT—abdominal aortic aneurysm	3.99e-05	0.0013	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOE—abdominal aortic aneurysm	3.91e-05	0.00128	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOE—abdominal aortic aneurysm	3.91e-05	0.00128	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.57e-05	0.00116	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.33e-05	0.00109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.29e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.29e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.07e-05	0.001	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.07e-05	0.001	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.55e-05	0.000833	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.53e-05	0.000824	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.36e-05	0.000772	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.35e-05	0.000767	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.35e-05	0.000767	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.32e-05	0.000759	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.32e-05	0.000759	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.32e-05	0.000756	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	2.28e-05	0.000745	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	1.99e-05	0.00065	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.59e-05	0.000518	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	1.05e-05	0.000344	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	1.03e-05	0.000337	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	7.07e-06	0.000231	CbGpPWpGaD
